Artificial Intelligence (AI)-Enhanced Chronic Obstructive Sleep Apnea Coach Global Market Report 2025

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market size has grown rapidly in recent years. It will grow from $1.35 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 19.6%. Growth during the historic period can be attributed to the rising incidence of sleep apnea disorders, increasing awareness of sleep-related health concerns, a growing elderly population susceptible to respiratory issues, higher obesity rates contributing to obstructive sleep apnea, expanded healthcare insurance coverage for sleep treatments, and greater diagnosis rates through sleep studies.

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market size is expected to see rapid growth in the next few years. It will grow to $3.26 billion in 2029 at a compound annual growth rate (CAGR) of 19.3%. Growth during the forecast period can be attributed to the increasing demand for personalized sleep management programs, greater focus on preventive healthcare and wellness monitoring, rising healthcare expenditure in emerging economies, growing adoption of home-based sleep monitoring solutions, expansion of reimbursement policies for digital health interventions, and heightened emphasis on early detection and chronic disease management. Key trends expected during the forecast period include technological progress in artificial intelligence (AI)-based sleep pattern analysis, innovations in wearable biosensors for real-time respiratory monitoring, advancements in cloud-based platforms for sleep data integration, development of predictive analytics for preventing apnea episodes, research and development in multimodal patient engagement algorithms, and innovation in digital twin models for individualized sleep therapy.

The rising prevalence of sleep disorders is expected to drive the growth of the artificial intelligence (AI) enhanced chronic obstructive sleep apnea coach market in the coming years. Sleep disorders are medical conditions that disrupt normal sleep, affecting sleep quality, overall health, and daily functioning. The growing number of sleep disorders is primarily due to increasing stress levels, as modern work demands, academic pressure, and excessive screen exposure contribute to anxiety and irregular sleep patterns. An artificial intelligence (AI) enhanced chronic obstructive sleep apnea coach helps manage these disorders by monitoring breathing and sleep patterns while offering personalized guidance and therapeutic support, allowing early identification of complications and improving sleep quality and general well-being. For example, in November 2023, according to the National Health Service, a UK-based government health statistics organization, the proportion of young individuals aged 17 to 23 years experiencing sleep issues three or more times in the previous week increased slightly to 64.9%, up from 64% in 2022. Thus, the rising prevalence of sleep disorders is contributing to the growth of the artificial intelligence (AI) enhanced chronic obstructive sleep apnea coach market.

Leading companies in the artificial intelligence (AI) enhanced chronic obstructive sleep apnea coach market are concentrating on developing advanced products such as positive airway pressure (PAP) devices that offer personalized therapy and facilitate remote monitoring through AI-based insights. Positive airway pressure (PAP) devices provide a consistent or adjustable airflow through a mask to keep airways open during sleep, preventing collapse in individuals with obstructive sleep apnea and improving breathing and sleep quality. For instance, in February 2024, ResMed Inc., a US-based medical device and digital health company, introduced the AirCurve 11 series bilevel devices. These devices deliver two pressure levels, with higher pressure during inhalation and lower pressure during exhalation, enabling healthcare providers to manage sleep apnea more effectively and helping patients remain consistent with therapy. The AirCurve 11 devices are built on the AirSense 11 platform and include digital features such as secure data transfer via cellular communication, automatic software updates, and patient engagement tools through the myAir app. The series includes models designed for both obstructive and central sleep apnea, aiming to enhance comfort and adherence through personalized therapy. The devices are available in the United States, with plans for a global launch.

In May 2024, Aeroflow Sleep, a US-based provider of continuous positive airway pressure therapy and sleep apnea supplies through insurance, partnered with EnsoData to enable its care teams across the United States to proactively manage patients with chronic obstructive sleep apnea using predictive artificial intelligence. Through this collaboration, Aeroflow Sleep aims to improve patient adherence by leveraging EnsoData’s positive airway pressure (PAP) therapy prediction model, EnsoTherapy, to identify patients at risk of non-compliance, provide timely coaching assistance, and enhance long-term outcomes in sleep apnea care. EnsoData is a US-based artificial intelligence company specializing in predictive sleep analytics and data-driven solutions for sleep medicine.

Major players in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market are Koninklijke Philips N.V., ResMed Inc., Sleep Number Corporation, Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Verily Life Sciences LLC, Natus Medical Incorporated, SomnoMed Limited, BMC Medical Co., Ltd., Eight Sleep, Inc., Sleepiz AG, Sleep.ai B.V. (SleepScore Labs), EnsoData, Inc., SovaSage, Inc., Somnics Inc., Sleep Doctor, LLC, Sommetrics, Inc., Nyxoah S.A., Neru Health Inc., and Apnea-Tech Limited.

North America was the largest region in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market statistics, including artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach industry global market size, regional shares, competitors with an artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market share, detailed artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach industry. The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Artificial intelligence (AI) enhanced chronic obstructive sleep apnea coach is a digital health solution designed to continuously monitor sleep patterns and respiratory parameters to support effective disease management. It processes real-time data and provides personalized guidance to improve therapy adherence and lifestyle modifications. The system enables early detection of complications, enhances treatment effectiveness, and improves overall sleep quality.

The primary components of an artificial intelligence (AI) enhanced chronic obstructive sleep apnea coach include software, hardware, and services. Software comprises AI-powered applications and algorithms that evaluate sleep data, generate personalized insights, and offer real-time coaching for effective management of sleep apnea. The deployment modes include cloud-based and on-premises solutions, used for applications such as home care, sleep clinics, hospitals, research institutions, and others. The major end users include patients, healthcare providers, sleep specialists, and other related professionals.

The countries covered in the artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market consists of revenues earned by entities by providing services such as remote patient monitoring, therapy adherence support, personalized health coaching, teleconsultation, sleep data analysis, and patient education and engagement. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced chronic obstructive sleep apnea coach market also includes sales of wearable sleep trackers, smart continuous positive airway pressure devices, connected pulse oximeters, and cloud-based monitoring platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.